![]()
|
|
||||||||
(Received for publication, September 10, 1996, and in revised form, October 24, 1996)
From the Mammalian Cell and Molecular Biology Laboratory,
Department of Biology and Molecular Biology Institute, San Diego State
University, San Diego, California 92182-0057
It is known that hepatic levels of reduced
glutathione correlate with the activity of the liver-specific enzyme
cholesterol-7
Volume 272, Number 5,
Issue of January 31, 1997
pp. 3099-3102
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
-Hydroxylase by
Dexamethasone in L35 Hepatoma Cells Requires Sulfhydryl Reducing
Agents
-hydroxylase. We examined the possibility that
sulfhydryl reducing agents activate transcription of cholesterol
7
-hydroxylase. Adding dithiothreitol (DTT, 1 mM) and
dexamethasone to L35 hepatoma cells increased the content of
7
-hydroxylase mRNA 3-fold above the levels observed with
dexamethasone alone. Without dexamethasone, DTT had no affect. The
addition of reduced glutathione to L35 cells demonstrated a similar
potentiation of expression dependent on dexamethasone. Nuclear
run-on assays showed that in the presence of both dexamethasone and
DTT, the transcription of the 7
-hydroxylase gene was clearly increased. In contrast, by itself, dexamethasone did not cause a
detectable increase in the transcription of the 7
-hydroxylase gene.
Dexamethasone and DTT did not affect the transcription of
-actin,
suggesting a selective induction of the 7
-hydroxylase gene. DTT
reversed repression of 7
-hydroxylase expression by insulin but not
the repression by phorbol ester. Our data show for the first time that
the sulfhydryl redox potential of the hepatocyte (i.e.
level of reduced glutathione) has a marked influence on the
transcription and expression of the liver-specific gene 7
-hydroxylase.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Onesto, E. Berra, R. Grepin, and G. Pages Poly(A)-binding Protein-interacting Protein 2, a Strong Regulator of Vascular Endothelial Growth Factor mRNA J. Biol. Chem., August 13, 2004; 279(33): 34217 - 34226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kang, N. J. Spann, T. Y. Hui, and R. A. Davis ARP-1/COUP-TF II Determines Hepatoma Phenotype by Acting as Both a Transcriptional Repressor of Microsomal Triglyceride Transfer Protein and an Inducer of CYP7A1 J. Biol. Chem., August 15, 2003; 278(33): 30478 - 30486. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Davis, J. H. Miyake, T. Y. Hui, and N. J. Spann Regulation of cholesterol-7{alpha}-hydroxylase: BAREly missing a SHP J. Lipid Res., April 1, 2002; 43(4): 533 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Miyake, S.-L. Wang, and R. A. Davis Bile Acid Induction of Cytokine Expression by Macrophages Correlates with Repression of Hepatic Cholesterol 7alpha -Hydroxylase J. Biol. Chem., July 14, 2000; 275(29): 21805 - 21808. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Baker, S.-L. Wang, D. J. Bell, C. A. Drevon, and R. A. Davis One or More Labile Proteins Regulate the Stability of Chimeric mRNAs Containing the 3'-Untranslated Region of Cholesterol-7alpha -hydroxylase mRNA J. Biol. Chem., June 23, 2000; 275(26): 19985 - 19991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |